Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.

Immunologic research - 1 Jan 2002

Dorak M Tevfik, Folayan Gbolahan O, Niwas Santosh, van Leeuwen Dirk J, Yee Leland J, Tang Jianming, Kaslow Richard A

Abstract excerpt

We explored the influence of the major CCR5 promoter or coding region variants as haplotypes and genotypes in a cohort of 250 chronically infected HCV patients receiving combined interferon/ ribavirin therapy. No haplotype, including the D32-bearing haplotype (G*2) reportedly associated in homozygotes with high HCV viral load (VL), showed a similar effect. Patients with genotype C/G*2 showed slightly lower median...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C, Chronic
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Receptors, CCR2

Share to Receptors, CCR5

Share to Receptors, Chemokine

Share to Ribavirin

Share to Viremia

Source

Identifiers

PMID: 12403355
DOI: 10.1385/IR:26:1-3:167

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.PMID 12403355Read ↗

HCV genotypes in chronic hepatitis C and response to interferonSemantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.Semantic proximity Read ↗

The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin.Semantic proximity Read ↗

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.Semantic proximity Read ↗

Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes.Semantic proximity Read ↗

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.Semantic proximity Read ↗

Clinical significance of the CCR5delta32 allele in hepatitis C.Semantic proximity Read ↗

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection.Semantic proximity Read ↗

CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population.Semantic proximity Read ↗

The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.Semantic proximity Read ↗

Association of low-density lipoprotein receptor genotypes with hepatitis C viral load.Semantic proximity Read ↗

CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.